2004, Number 1
<< Back Next >>
Gac Med Mex 2004; 140 (1)
Consensus of a Group of Mexican Experts: Efficacy and Safety of Metamizol (Dipirone).
Arcila-Herrera H, Barragán-Padilla S, Borbolla-Escoboza JR, Canto-Solís A, Castañeda-Hernández G, de León-González M, Genis-Rondero MA, Granados-Soto V, Gutiérrez-García JL, Hernández-Hernández S, Kassian-Rank A, Lara-Perera V, Vargas-Correa JB
Language: Spanish
References: 5
Page: 99-102
PDF size: 424.28 Kb.
Text Extraction
No Abstract
REFERENCES
Ortiz MI, Castañeda-Hernández G, Granados-Soto V. Possible involvement of potassium channels in peripheral antinociception induced by metamizol: lack of participation of ATP-sensitive K+ channels. Pharmacol Biochem Behav 2003;74:465-470.
García-Martínez JM, Fresno-Vara JA, Lastres P, Bernabéu C, Ortiz Betés P, Marín-Pérez J. Effect of metamizol on promyelocytic and terminally differentiated granulocytic cells. Comparative analysis with acetylsalicylic acid and diclofenac. Biochem Pharmacol 2003;65:209-217.
Andrade SE, Martínez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1997;51:1357-1365.
IAAAS. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. J Am Med Assoc 1986;256:1749-157.
Vargas Correa JB, Canto Solís A, Arcila Herrera H, Morales Adrián J, Vidal León JM, Valle Acevedo LJ. Metamizol. Evaluación del riesgo para agranulocitosis y anemia aplástica. Med Int Mex 1999;15(1):6-10.